BEUDAMED
    FDA PMA FDA Class 3 Approved 🇺🇸 United States

    Implant, Dermal, For Aesthetic Use

    PMA: P050047 · Supplement: S087 · Decision May 3, 2023
    View on FDA
    Classifications
    1
    FEI Numbers
    29
    Registration Numbers
    29

    Basic Information

    Device Name
    Implant, Dermal, For Aesthetic Use
    Trade Name
    Juvéderm Ultra, Ultra XC, and Ultra Plus XC, Juvéderm Ultra XC
    PMA Number
    P050047
    Supplement Number
    S087
    Device Class
    FDA Class 3
    Product Code
    LMH
    Generic Name
    Implant, dermal, for aesthetic use
    Medical Specialty
    Unknown
    Advisory Committee
    General, Plastic Surgery
    Decision
    Approved
    Decision Code
    APPR
    Decision Date
    May 3, 2023
    Date Received
    April 4, 2023
    Supplement Type
    Special (Immediate Track)
    Supplement Reason
    Labeling Change - Indications/instructions/shelf life/tradename
    Expedited Review
    N

    Advisory Committee Statement

    Approval for revisions to the clinician labeling and patient labeling of Juvéderm Ultra, Ultra XC, and Ultra Plus XC, Juvéderm Ultra XC, Juvéderm Voluma XC, Juvéderm Vollure XC, Juvéderm Volbella XC, and Juvéderm Volux XC as a result of postmarket surveillance data.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    LMH Implant, Dermal, For Aesthetic Use